Dermatology NewsMeta-analysis eyes impact of adherence to HCQ among SLE patientsFebruary 10, 2020Autoimmune Diseases
Dermatology NewsVEDOSS study describes predictors of progression to systemic sclerosisDecember 12, 2019Autoimmune DiseasesRare Diseases
Dermatology NewsTULIP trials show clinical benefit of anifrolumab for SLEDecember 5, 2019Autoimmune Diseases
Dermatology NewsGlucocorticoids linked to damage accrual in SLE regardless of disease activityDecember 3, 2019Autoimmune Diseases
Dermatology NewsFewer people are dying from systemic sclerosis at younger agesNovember 21, 2019Rare DiseasesAutoimmune Diseases
Dermatology NewsCVD risk in black SLE patients 18 times higher than in whitesNovember 11, 2019Autoimmune Diseases
Dermatology NewsVitiligo: First-ever RCT is smashing successOctober 29, 2019Pigmentation DisordersAutoimmune Diseases
Dermatology NewsLow disease activity a valid target in early SLE, investigators sayOctober 17, 2019Autoimmune Diseases
Dermatology NewsSystemic sclerosis raises risk of breast cancer, lung cancer, melanomaOctober 2, 2019Autoimmune DiseasesMelanoma
Dermatology NewsZostavax proves safe, effective in patients with nonactive SLESeptember 27, 2019Autoimmune Diseases
Dermatology NewsStudy aims to define symptoms of Sjögren’s syndrome secondary to SLESeptember 21, 2019Medical DermatologyAutoimmune Diseases
Dermatology NewsFDA approves nintedanib for scleroderma interstitial lung diseaseSeptember 7, 2019Autoimmune Diseases
